Page 10 - 医疗企业管理创新路径研究
P. 10
第四节 保健食品进口合规策略 ···················································· 115
第五节 我国保健食品法律法规发展历程 ········································ 117
第六节 药品追溯码在审计中的应用 ·············································· 120
第五章 民法典对企业发展的影响 ······················································· 125
第一节 民法典的诚实信用原则及其对企业发展的影响 ······················ 125
第二节 关于民法典信用体系构建的思考 ········································ 144
第六章 医药企业管理和医药项目管理 ················································· 159
第一节 医药企业优化成本管理的策略 ··········································· 159
第二节 全过程成本管理在医药制造企业中的运用 ···························· 164
第三节 医药企业业财融合路径 ···················································· 169
第四节 医药企业新药研发项目管理的优化策略 ······························· 175
第五节 医药企业研发项目研发费用有效管理 ·································· 178
第七章 卫生健康制度、卫生改革与卫生管理体系的信息化建设 ················ 183
第一节 基本医疗卫生制度的研究 ················································· 183
第二节 深化医药卫生体制改革的途径 ··········································· 184
第三节 信息化系统在卫生管理中的应用 ········································ 190
第八章 生物医药行业和医药企业创新发展 ··········································· 195
第一节 生物医药行业创新发展 ···················································· 195
第二节 主要国家生物医药产业创新体系建设经验 ···························· 198
第三节 新形势下生物医药企业加强内部控制 ·································· 203
第九章 加强药事管理的质量控制 ······················································· 207
第一节 药品质量管理及控制标准制订与解析 ·································· 207
第二节 “三位一体”的高质量药事管理 ········································ 212
第三节 PDCA 循环管理法在医院药事管理中的应用价值 ··················· 215
第十章 医疗器械的管理研究 ····························································· 219
第一节 医疗器械全流程质量管理体系的构建路径 ···························· 219
第二节 风险管理在医疗器械质量管理中的应用 ······························· 224
参考文献······················································································· 231
